Aug 2026· Small· Vol 22· 1 citation· 148 references
Medicine
TL;DR
This review focuses on recent progress in engineering CMNPs with precise control over size, coating integrity, and membrane leaflet orientation, and analyzes how synthetic parameters influence the particle size and size distribution of CMNPs.
Abstract
ABSTRACT Cell membrane‐coated nanoparticles (CMNPs) represent an advanced class of biomimetic nanomaterials that integrate the functional complexity of natural cell membranes with the tunable properties of synthetic nanoparticle cores. By inheriting native membrane proteins, lipids, and glycans, CMNPs exhibit attractive properties such as enhanced immune evasion, prolonged circulation, and cell‐specific interactions, thereby supporting a wide range of therapeutic, diagnostic, and biomedical applications. However, precise control over CMNPs fabrication remains challenging, particularly with respect to particle size, membrane coating integrity, and membrane leaflet orientation, all of which critically influence biological performance. This review focuses on recent progress in engineering CMNPs with precise control over size, coating integrity, and membrane leaflet orientation. It first analyzes how synthetic parameters influence the particle size and size distribution of CMNPs, then outlines strategies to improve membrane coating integrity together with the corresponding evaluation methods and discusses approaches to regulate membrane leaflet orientation and the analytical techniques used for its assessment. Finally, this review highlights remaining challenges and future directions for the rational design of CMNPs, supporting their continued development toward translational nanomedicine applications.
Biomimetic cell membrane-coated nanoparticles (CM-NPs) have emerged as a promising class of nanocarriers that integrate the tunable physicochemical properties of engineered nanoparticles with selected biological features of naturally derived cell membranes. By retaining membrane-associated proteins, lipids, glycans, an...
This work highlights membrane engineering-enabled biological regulation of nanomaterials, offering rational guidelines for the design and scalable fabrication of next-generation biomimetic nanotherapeutics.
Hong-Yu Yang, Xin-Yuan Zhu, You-Fu Wang et al.· ACS Applied Materials and In...· 0 citations
Cell membrane coating offers a biomimetic strategy for drug delivery by combining the biological functions of natural membranes with the tunable properties of synthetic nanoparticles (NPs). The coating process influences membrane coverage and the biological performance of the resulting particles, making the selection o...
Moataz B. Zewail, Yun Liu, Yi-Long Fan et al.· Aggregate· 0 citations
Bioinspired and biomimetic membranes represent a rapidly advancing class of materials for biomedical and life-science applications by emulating the structure and function of natural biological systems. This review represents the current progress in these technologies, including membrane-coated nanoparticles, tissue-eng...
H. K., M. S. Sowndarya, S. Rohini et al.· ACS Biomaterials Science & E...· 0 citations
Plant-derived nanovesicles (PDNVs) are lipid-bilayer vesicles containing diverse lipids, proteins, nucleic acids and small bioactive molecules. Their favorable biocompatibility, natural membrane interfaces and intrinsic biological activities make them attractive nanocarriers. However, their broader application is restr...
Ning-Tao Yuan, Tao Meng, Hong Bi· Frontiers in Materials· 0 citations
This review examines recent advances in LbL-engineered LBNs, focusing on how multilayer surface architecture reshapes physicochemical properties, cargo localization and release, biological identity, cellular interactions, and transport across physiological barriers.
Eunseo Jang, Gaeun Lee, Yoseph Seo et al.· Pharmaceutics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.